|
A Quebec City biopharmaceutical company, which began clinical trials on humans on Monday for a plant-derived COVID-19 vaccine, is among at least five Canadian research groups deep in the hunt for a vaccine. Medicago is the first Canadian company to administer doses of a potential vaccine to volunteers, 180 men and women aged 18 to 55 who will receive two doses 21 days apart. The company expects to have safety and efficacy results for the two doses in October.
|